Kongressthemen
With the explosive excitement and clinical proof of concept utilizing CD47 approaches, 2020 is the year for macrophage development, as we witness greater interest and investment in new work on novel macrophage targets outside of CD47.
Tumor Myeloid Microenvironment Directed Therapeutics Summit is focused on optimizing the potential of immunotherapy, through direct modulation of tumor-resident myeloid populations to retune the microenvironment for improved response rates to therapy.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/701752-3?pid=4832
Speakers: Peter Ellmark, Alligator Bioscience AB, Victoria Smith, Amphivena Therapeutics Inc., Kaiming Ye, Binghamton University, Michael Klichinsky, Carisma Therapeutics and more
https://go.evvnt.com/701752-0?pid=4832
Frau Aarti Diwan
KategorienAllgemeinmedizin, Gesundheitsversorgung
